Protein blocking Combination therapies starting to take hold in cancer therapy. Adding an immunotherapy drug to the oncology treatment has taken the results from not statistically significant to efficacious!!!
Sound familiar!
https://www.biopharmadive.com/news/astrazeneca-tremelimumab-liver-cancer-study-survival/608311/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202021-10-15%20BioPharma%20Dive%20%5Bissue:37383%5D&utm_term=BioPharma%20Dive
Protein blocking Combination therapies starting to take hold in...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.6¢ | $148.9K | 1.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48919 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 70000 | 1 |
View Market Depth
| Last trade - 15.59pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
0.000 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.7¢ | 43057 | ||
| Last updated 13.04pm 03/05/2024 ? | |||||
| PER (ASX) Chart |